Browse the evidence

Protein supplementation does not seem to provide further improvements in untrained and healthy subjects.

Practitioners should consider the training status of individuals when recommending protein supplementation.

The prevalence of any remission in the plate model was 27.1% during the first 2 years, decreasing over time.

The plate model may initially improve diabetes remission rates, but these rates decline over time.

People in Northern China often consume more plant-based foods.

Understanding local dietary habits can inform nutritional guidance and interventions.

At the lowest income level, the proportions of individuals in the best carbohydrate quality category reduced from 26.9% to 20.6%.

Practitioners should be aware that lower income is associated with reduced dietary quality in carbohydrates.

At the highest income level, the proportions of individuals in the best carbohydrate quality category increased from 22.9% to 26.6%.

Practitioners should recognize that higher income is associated with improved dietary quality in carbohydrates.

No significant differences were observed between the 4-6 RPE and 7-9 RPE groups for relative intensity or relative volume.

Training intensity and volume were similar between the two RPE groups, suggesting flexibility in training approaches.

No significant group × time interactions were observed between the two training protocols.

Both training approaches yield similar results, allowing flexibility in training intensity without compromising strength gains.

Trivial between-group effect sizes were observed when comparing the strength gains of the 4-6 RPE group to the 7-9 RPE group (g = -0.12).

The similarity in strength gains suggests that both training intensities may be equally effective for improving squat strength.

The findings regarding back squat strength improvements between resistance training with 4-6 RPE and 7-9 RPE are statistically inconclusive.

Further research may be needed to clarify the effectiveness of different RPE levels in resistance training.

The historical view that 'a calorie is a calorie' is an oversimplification.

Practitioners should be cautious of oversimplified views on calorie intake.

The reanalysis of the randomized crossover trial did not support the carbohydrate-insulin model of obesity.

Practitioners should be cautious about claims supporting the carbohydrate-insulin model based on flawed analyses.

There were no significant differences in serum TMAO, fasting glucose, fasting insulin, or vitamin B12 between vegan and omnivorous twins after 4 or 8 weeks.

Practitioners may consider that a healthy omnivorous diet can yield similar clinical outcomes as a vegan diet.

No significant differences were observed between the vegan and omnivorous diets for secondary outcomes of triglycerides or HDL-C.

The type of diet may not significantly affect triglycerides or HDL cholesterol levels.

Even after bariatric surgery, patients may not lose the expected amount of weight or may experience weight regain.

Understand that bariatric surgery may not guarantee weight loss success and additional support may be needed.

The current care for people with obesity in Germany is inadequate and relies on non-reimbursed services.

Practitioners should advocate for better reimbursement policies to improve obesity care.

The metabolic phenotype of the people of Bangladesh is different from Caucasians.

Understanding these differences is crucial for effective obesity management strategies.

Obesity threatens to affect 30% of the world's population by 2030.

Health professionals should be aware of the rising obesity rates and their implications.

Barriers to treatment for obesity-related hypertension include obesity stigma, limited access to healthcare, and adherence problems.

Addressing stigma and improving access to care are crucial for effective management of obesity-related hypertension.

The prevalence of obesity has increased four-fold over the four preceding decades, with concomitantly rising rates of hypertension.

Healthcare providers should be aware of the significant rise in obesity and hypertension prevalence.

Sub-chronic administration of 0839 and 0833 reduced food intake and body weight in DIO mice and rats.

These compounds may help in managing weight in populations with diet-induced obesity.

No significant differences in efficacy and safety of the drugs were found between age groups.

Efficacy and safety of these drugs appear consistent, regardless of age.

Rates of obesity are projected to continue to increase, with severe obesity expected to be the most common body mass index category for women in the coming decade.

Practitioners should be aware of the increasing prevalence of obesity among women and its implications for health.

Adverse effects of tirzepatide are most often mild and well tolerated, with no significant impact on patients’ quality of life.

Tirzepatide may be a safe option for patients concerned about side effects.

Obesity treatment could generate a social return on investment of $3.81 per dollar nationally and $8.57 from states’ perspective.

Investing in obesity treatment can yield significant economic returns for states and the nation.